$167 Million is the total value of Prosight Management, LP's 36 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 76.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Buy | PROTHENA CORP PLC | $21,785,000 | -5.4% | 441,000 | +36.4% | 13.04% | +2.9% |
| GLPG | Buy | GALAPAGOS NVspon adr | $19,069,000 | +44.6% | 345,900 | +38.0% | 11.42% | +57.3% |
| ALBO | Buy | ALBIREO PHARMA INC | $11,973,000 | -13.8% | 514,082 | +15.5% | 7.17% | -6.2% |
| Buy | GALAPAGOS NVcall | $11,043,000 | +109.9% | 200,300 | +100.3% | 6.61% | +128.4% | |
| CUE | Buy | CUE BIOPHARMA INC | $9,376,000 | -1.8% | 829,042 | +26.5% | 5.61% | +6.9% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $7,974,000 | +235.7% | 122,187 | +286.1% | 4.77% | +265.3% |
| OSCR | Buy | OSCAR HEALTH INCcl a | $7,261,000 | +121.6% | 925,000 | +391.0% | 4.35% | +141.2% |
| CNVY | Buy | CONVEY HEALTH SOLUTIONS HLDG | $6,496,000 | +4.8% | 777,000 | +5.3% | 3.89% | +14.0% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $6,019,000 | +10.6% | 360,000 | -42.9% | 3.60% | +20.3% |
| ZGNX | Sell | ZOGENIX INC | $5,897,000 | -20.9% | 362,909 | -26.1% | 3.53% | -13.9% |
| CRL | New | CHARLES RIV LABS INTL INC | $5,833,000 | – | 15,481 | +100.0% | 3.49% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $5,419,000 | +20.7% | 409,620 | +59.1% | 3.24% | +31.3% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,411,000 | – | 31,907 | +100.0% | 3.24% | – |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $4,621,000 | -28.4% | 1,155,300 | +57.2% | 2.77% | -22.1% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,182,000 | -54.2% | 45,000 | -70.7% | 2.50% | -50.2% |
| AGL | Buy | AGILON HEALTH INC | $4,050,000 | +41.1% | 150,000 | +37.0% | 2.42% | +53.5% |
| MORF | Buy | MORPHIC HLDG INC | $3,454,000 | -12.9% | 72,898 | +4.1% | 2.07% | -5.2% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $2,857,000 | +21.0% | 356,617 | +26.3% | 1.71% | +31.5% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $2,810,000 | – | 128,705 | +100.0% | 1.68% | – |
| New | PROTHENA CORP PLCcall | $2,574,000 | – | 52,100 | +100.0% | 1.54% | – | |
| Sell | PROGYNY INCput | $2,518,000 | -18.2% | 50,000 | -9.1% | 1.51% | -11.1% | |
| STTK | Buy | SHATTUCK LABS INC | $2,215,000 | -35.8% | 260,243 | +53.8% | 1.33% | -30.1% |
| New | COGNITION THERAPEUTICS INC | $1,909,000 | – | 301,979 | +100.0% | 1.14% | – | |
| PANA | Buy | PANACEA ACQUISITION CORP II | $1,900,000 | +2.9% | 195,855 | +3.7% | 1.14% | +11.9% |
| GMED | New | GLOBUS MED INCcl a | $1,458,000 | – | 20,188 | +100.0% | 0.87% | – |
| ACCD | Sell | ACCOLADE INC | $1,318,000 | -68.1% | 50,000 | -49.0% | 0.79% | -65.3% |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,316,000 | – | 17,364 | +100.0% | 0.79% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $1,313,000 | -80.6% | 68,800 | -75.0% | 0.79% | -78.9% |
| SIOX | Buy | SIO GENE THERAPIES INC | $1,035,000 | -3.3% | 802,180 | +62.6% | 0.62% | +5.3% |
| MRNA | New | MODERNA INC | $940,000 | – | 3,700 | +100.0% | 0.56% | – |
| New | WEST PHARMACEUTICAL SVSC INCput | $704,000 | – | 1,500 | +100.0% | 0.42% | – | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $564,000 | – | 166,775 | +100.0% | 0.34% | – |
| New | PROCEPT BIOROBOTICS CORP | $500,000 | – | 20,000 | +100.0% | 0.30% | – | |
| XCUR | Sell | EXICURE INC | $490,000 | -92.0% | 2,426,508 | -52.7% | 0.29% | -91.3% |
| ODT | New | ODONATE THERAPEUTICS INC | $404,000 | – | 298,900 | +100.0% | 0.24% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $358,000 | – | 53,815 | +100.0% | 0.21% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -70,563 | -100.0% | -0.08% | – | |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -44,225 | -100.0% | -0.15% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -55,411 | -100.0% | -0.28% | – |
| ORGO | Exit | ORGANOGENESIS HLDGS INC | $0 | – | -38,000 | -100.0% | -0.30% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -38,774 | -100.0% | -0.31% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -27,378 | -100.0% | -0.34% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -265,634 | -100.0% | -0.51% | – |
| CLLS | Exit | CELLECTIS S Aspon ads | $0 | – | -87,103 | -100.0% | -0.60% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -3,300 | -100.0% | -0.71% | – |
| WAT | Exit | WATERS CORP | $0 | – | -4,000 | -100.0% | -0.79% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -13,000 | -100.0% | -1.05% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -37,396 | -100.0% | -1.20% | – |
| Exit | IOVANCE BIOTHERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -1.36% | – | |
| ABBV | Exit | ABBVIE INC | $0 | – | -24,800 | -100.0% | -1.47% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -38,319 | -100.0% | -1.49% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -15,000 | -100.0% | -1.50% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -20,000 | -100.0% | -1.64% | – |
| HUM | Exit | HUMANA INC | $0 | – | -9,000 | -100.0% | -1.93% | – |
| MGTX | Exit | MEIRAGTX HLDGS PLC | $0 | – | -291,080 | -100.0% | -2.11% | – |
| MTCR | Exit | METACRINE INC | $0 | – | -1,145,034 | -100.0% | -2.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-01 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.